Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
17,197
-70.41%
|
$1,203,790
$70.2 P/Share
|
|
Sep 28
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,197
+43.38%
|
$343,940
$20.04 P/Share
|
|
Sep 25
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.7%
|
$740,082
$67.9 P/Share
|
|
Sep 24
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$650,000
$65.5 P/Share
|
|
Sep 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.09%
|
$325,000
$65.33 P/Share
|
|
Sep 23
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Sep 23
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$603,000
$67.99 P/Share
|
|
Sep 23
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.26%
|
$1,005,000
$67.27 P/Share
|
|
Sep 23
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.51%
|
$0
$0.99 P/Share
|
|
Sep 21
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-62.76%
|
$1,340,000
$67.57 P/Share
|
|
Sep 21
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.67%
|
$400,000
$20.04 P/Share
|
|
Sep 21
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
8,587
-0.09%
|
$583,916
$68.56 P/Share
|
|
Sep 18
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.68%
|
$751,128
$68.16 P/Share
|
|
Sep 17
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$680,000
$68.46 P/Share
|
|
Sep 16
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Sep 16
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$603,000
$67.69 P/Share
|
|
Sep 14
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-0.26%
|
$1,240,000
$62.13 P/Share
|
|
Sep 14
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.51%
|
$0
$0.99 P/Share
|
|
Sep 14
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,034
-47.78%
|
$1,242,108
$62.26 P/Share
|
|
Sep 14
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,034
+27.88%
|
$360,612
$18.1 P/Share
|
|
Sep 11
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.32%
|
$640,668
$58.6 P/Share
|
|
Sep 10
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
17,030
-0.1%
|
$953,680
$56.96 P/Share
|
|
Sep 09
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Sep 09
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$495,000
$55.81 P/Share
|
|
Sep 08
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,467
-55.96%
|
$1,482,152
$56.32 P/Share
|
|
Sep 08
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,467
+28.01%
|
$423,472
$16.63 P/Share
|
|
Sep 04
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.52%
|
$673,806
$61.91 P/Share
|
|
Sep 03
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$650,000
$65.65 P/Share
|
|
Sep 03
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.51%
|
$650,000
$65.65 P/Share
|
|
Sep 03
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.51%
|
$0
$0.99 P/Share
|
|
Sep 02
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.51%
|
$620,000
$62.89 P/Share
|
|
Sep 02
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.51%
|
$0
$0.99 P/Share
|
|
Sep 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
|
Sep 02
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$558,000
$62.89 P/Share
|
|
Sep 01
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
9,247
-0.1%
|
$582,561
$63.54 P/Share
|
|
Aug 31
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-67.58%
|
$1,920,000
$64.65 P/Share
|
|
Aug 31
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+30.0%
|
$480,000
$16.63 P/Share
|
|
Aug 28
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.84%
|
$740,082
$67.06 P/Share
|
|
Aug 27
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$690,000
$69.91 P/Share
|
|
Aug 26
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
|
Aug 26
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$603,000
$67.45 P/Share
|
|
Aug 24
2020
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,000
-59.42%
|
$1,625,000
$65.45 P/Share
|
|
Aug 24
2020
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+34.52%
|
$425,000
$17.43 P/Share
|
|
Aug 24
2020
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-0.2%
|
$1,300,000
$65.43 P/Share
|
|
Aug 24
2020
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.51%
|
$0
$0.99 P/Share
|
|
Aug 21
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.82%
|
$740,082
$67.06 P/Share
|
|
Aug 20
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
18,824
-0.11%
|
$1,261,208
$67.8 P/Share
|
|
Aug 19
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.01%
|
-
|
|
Aug 19
2020
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.13%
|
$594,000
$66.74 P/Share
|
|
Aug 17
2020
|
Flagship Ventures Fund Iv General Partner LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
11,053,049
-52.3%
|
-
|